Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    International Journal for Radiation Physics and Chemistry 6 (1974), S. 187-201 
    ISSN: 0020-7055
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology , Energy, Environment Protection, Nuclear Power Engineering , Physics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1569-8041
    Keywords: docetaxel ; gemcitabine ; pancreatic cancer
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: Gemcitabine and docetaxel have been claimed to be active single agents in advanced pancreatic cancer. We determined the maximum tolerable dose of docetaxel combined with a weekly fixed dose of gemcitabine and assessed the activity of this combination in advanced pancreatic cancer. Patients and methods: Phase I. Patients were treated with gemcitabine on days 1 and 8, every three weeks, at a fixed dose of 1,000 mg/m2; docetaxel was given at escalating doses starting from 70 mg/m2 on day 8. Phase II. In accord with the optimal two-stage phase II study design, 18 patients were treated with gemcitabine (1000 mg/m2) and the maximum tolerable dose of docetaxel (70 mg/m2). Results: Phase I. Dose-limiting toxicities occurred at the second dose level of docetaxel (80 mg/m2), with all three patients developing grades 3 or 4 neutropenia. Consequently, the dose tested in the phase II study was 70 mg/m2. Phase II. In the 18 patients enrolled in the study, we registered only one partial response. The time to progression was 3 months, and the median treatment survival was 5.4 months. Grade 3–4 toxicities consisted of neutropenia (three episodes) and thrombocytopenia (two episodes). Furthermore, 10 patients complained of grade 3 fatigue. Conclusions: The addition of docetaxel to gemcitabine does not appear to be useful in advanced pancreatic cancer, since gemcitabine alone achieves similar results.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1433-7339
    Keywords: Key words 5-Fluorouracil ; Diarrhea ; Loperamide
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  Thirty-seven colorectal cancer patients with grade 1–4 diarrhea (NCICTC) caused by chemotherapy with 5-FU-containing regimens, received oral loperamide at the initial dose of 4 mg followed by 4 mg every 8 h (total dose 16 mg/24 h). Twenty-five patients (69%) were diarrhea-free and were considered to be treatment responders. Eight-four percent of the patients with grade 1 or 2 diarrhea achieved a response, but only 52% of those with grade 3–4 diarrhea. These data seem to suggest that high-dose loperamide is effective in patients with moderate diarrhea and can be regarded as the treatment of choice. The patients with more severe diarrhea did not respond so well, and should, perhaps, be given first-line treatment with more effective drugs, such as somatostatin analogues (e.g., octreotide).
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1569-8041
    Keywords: docetaxel ; gastric cancer ; second-line chemotherapy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background:Docetaxel has shown some activity in advanced gastriccancer. Recent phase I studies found low hematologic toxicity and a favourabletoxicity profile when docetaxel was administered on a weekly schedule. In thisstudy, we explored the activity of weekly docetaxel in patients with advancedgastric cancer who failed first-line chemotherapy. Materials and methods:Patients with stable or progressing diseaseafter first-line chemotherapy received 36 mg/m2 weekly docetaxel.One cycle consisted of six administrations followed by a two-weeks rest,patients were re-evaluated at week eight. The optimal two-stage design wasadopted for early stopping of the trial if responses were one or less in 21patients (〈20% response rate with α and β errorprobabilities 0.05 and 0.010 respectively). Results:Twenty-one patients have been enrolled and they are fullyevaluable for response and toxicity. One patient achieved partial response,8 patients had stable disease and 12 patients progressed. Median overallsurvival from the onset of salvage chemotherapy was 3.5 months. Hematologictoxicity was observed in two patients who experienced grade III leukopenia.Beginning from the third week of treatment, most of the patients (90%)showed grade II asthenia which resulted the commonest side-effect. Conclusions:This schedule of weekly docetaxel did not showsignificant activity in pretreated patients with advanced gastric cancer.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    New York, NY [u.a.] : Wiley-Blackwell
    Journal of Applied Polymer Science 26 (1981), S. 3643-3655 
    ISSN: 0021-8995
    Keywords: Chemistry ; Polymer and Materials Science
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology , Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics
    Notes: Single filaments of the polyterephthalamide of p-aminobenzylhydrazide (X-500) were prepared by spinning X-500 solutions in dimethyl sulfoxide (DMSO) using water as a coagulating agent. The polymer is known for its ability to develop ultrahigh modulus fibers and for having a semirigid chain conformation with a persistence length of ∼50 Å in DMSO. In the latter solvent, molecular rigidity appears to be just below that required for spontaneous formation of a nematic phase. The orientation of the fibers was performed in three different stages: during coagulation (I), in the washing bath following coagulation (II), and during postspinning treatments (III). Corresponding mechanical properties were determined. The results indicate that high elastic modulus (15 GPa) already appears during step I at very moderate pulloff ratios. Therefore, considerable orientation had already occurred in the flowing solution. Further increase of fiber orientation yields a large increase of modulus (from 22 to 67 GPa) during solid-state deformation (step III). The orientation of the flowing solution was monitored by viscosity and birefringence measurements. The results are discussed in terms of orientation due to elongational and shear flow and, possibly, a flow-induced transition to a nematic phase in the concentrated solution in which chain entanglement is shown to occur.
    Additional Material: 10 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...